South Korea sends two crypto cases to prosecutors
South Korea's Financial Services Commission (FSC) has referred suspects in two separate cryptocurrency market manipulation cases to prosecutors following its 12th regular meeting.
South Korea's Financial Services Commission (FSC) has referred suspects in two separate cryptocurrency market manipulation cases to prosecutors following its 12th regular meeting.
The Patent and Market Court in Stockholm delivered a judgment on Wednesday ordering Alphabet (NASDAQ:GOOGL) to pay 14.3 billion Swedish kronor (€1.3 billion) in antitrust damages.
Meta Platforms (NASDAQ:META) is building an internal cloud infrastructure business to sell excess artificial intelligence computing capacity after its shares rose over 6% in premarket trading.
JPMorgan (NYSE:JPM) has voiced its support for the CLARITY Act, a legislative proposal aimed at establishing clearer regulatory rules for digital assets in the United States.
Artelo Biosciences (NASDAQ:ARTL) reported new preclinical data for ART26.12, a selective FABP5 inhibitor currently in Phase 1 development, in a mouse model of spinal cord injury–related neuropathic pain.
Micron (NASDAQ:MU) and General Motors (NYSE:GM) signed a Strategic Customer Agreement to secure long-term supply of automotive memory and storage for GM’s next-generation vehicle platforms
60 Degrees Pharma (NASDAQ:SXTP) reported that an independent Data Safety Monitoring Board found no safety concerns in the first six patients in its Phase 2 B-Free chronic babesiosis study and recommended trial continuation.
Himax Technologies (Nasdaq:HIMX) said it plans to dispose of its investment in an equity-method investee after the startup agreed to be acquired by a third-party semiconductor company for $80 million in cash.
BTQ (NASDAQ:BTQ) received final approval from French foreign direct investment authorities to acquire all remaining shares of QPerfect, a quantum software company based in Strasbourg.
Vyome Holdings (NASDAQ:HIND) said the China National Intellectual Property Administration granted a patent covering formulation and therapeutic uses for its besifloxacin topical gel program.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy